Vitamin E Serum Levels and Bleeding Risk in Patients Receiving Oral Anticoagulant Therapy: a Retrospective Cohort Study

BACKGROUND: Hemorrhagic risk assessment is a crucial issue in patients with nonvalvular atrial fibrillation (NVAF) who are receiving oral anticoagulant therapy (OAT). Our aim was to analyze the relationship between vitamin E, which possesses anticoagulant properties, and bleeding events in NVAF pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pastori, Daniele, Carnevale, Roberto, Cangemi, Roberto, Saliola, Mirella, Nocella, Cristina, Bartimoccia, Simona, Vicario, Tommasa, Farcomeni, Alessio, Violi, Francesco, Pignatelli, Pasquale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886776/
https://www.ncbi.nlm.nih.gov/pubmed/24166490
http://dx.doi.org/10.1161/JAHA.113.000364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886776/
https://www.ncbi.nlm.nih.gov/pubmed/24166490
http://dx.doi.org/10.1161/JAHA.113.000364

Ejemplares similares